Introduction: January 27, 2024 marks the 60th anniversary of the establishment of diplomatic relations between China and France, and is a major anniversary of the good development of diplomatic relations between China and France.
In order to promote Sino-French cooperation and academic exchanges in biomedicine and health industry, on January 27, the "Sino-French Biomedical and Health Industry Cooperation and Exchange Conference (2024)" was held in Guangzhou. Mr. Ma Jun, Chief Technology Innovation Officer of Infinitus (China)**, attended the meeting on behalf of the company.
Mr. Ma Jun shared.
During the meeting, Mr. Ma Jun shared the theme of "Big Health Technology Innovation and High-quality Development of Industry", and said: "Infinitus has established the Hoffmann Infinitus Research Program with the French National Academy of Sciences and Professor Hoffmann's team, established the Paris Joint Laboratory of Triya International Skincare Research Center with the City University of Paris, and established a good cooperative relationship with experts such as Academician Daniel Zhang of the French National Academy of Pharmaceutical Sciences. Infinitus has carried out in-depth research with French research institutions, universities and experts on the core technologies of complex polysaccharides, and has continuously consolidated its leading position in the industry. ”
Hoffmann Infinitus Research Program plaque.
Plaque of the platform of Triya International Skincare Research Center.
Effect of complex polysaccharide composition extracted from shiitake mushroom, Poria cocos and Tremella fuciformis against influenza virus" obtained a patent certificate issued by the European Patent Office, patent number: EP3216454B1
The combination of compound polysaccharide products and Ganoderma lucidum polysaccharide products can repair the function of immune cells in aging mice, regulate the balance of pro-inflammatory and anti-inflammatory cytokines, enhance the antioxidant activity of the body, and delay the degeneration of immune organs to a certain extent. The results have been published in CYTA - Journal of Food, 2023, 21(1): 433-441
At the same time, Mr. Ma Jun also emphasized the positive impact of the Sino-French scientific research platform cooperation on the development of the big health industry, and he shared with the team of Professor Hoffmann, the winner of the 2011 Nobel Prize in Physiology or Medicine, as an example: "Professor Hoffman's team has led the research and development of natural immune mechanisms, and in the course of 7 years of cooperation with Professor Hoffman's team, Chinese and French researchers have overcome various difficulties to verify the efficacy of Chinese herbal compound polysaccharides, and clarified part of its mechanism of action for regulating immunity and antiviral. Jointly promote the application of Chinese herbal medicine in the field of immunity, so that the traditional health culture of Chinese medicine and food homology and modern technology are organically combined and shared with peers all over the world. ”
Academician Daniel Zhang shared.
Academician Daniel Zhang of the French National Academy of Pharmaceutical Sciences and Sorbonne University of France shared the theme of "Sino-French scientific research cooperation empowers innovative drug research and development" at the conference, in which he reviewed the past cooperation with Infinitus, and said: "Infinitus and I have cooperated on the research and application of polysaccharides in the big health industry. Polysaccharides have a wide range of pharmacological effects, such as enhancing immunity, anti-tumor, antiviral, hypoglycemic, and protecting gastrointestinal function, and are hot spots in the research and development of health food. ”
This exchange meeting has built a valuable platform for the cooperation between China and France in the field of biomedicine and health, and the participants will find more cooperation opportunities through academic exchanges and industrial cooperation sharing. In the future, Infinitus will continue to leverage its scientific research advantages and cooperate with authoritative scientific research institutions, well-known universities and experts at home and abroad to build a multi-party scientific research and technology platform under the overall guidance of "E (Oriental Wisdom) + W (Modern Technology) W (Spread to the World)", so as to maximize the transformation and application of basic research, and drive product development with user-centered innovation to bring consumers a healthier and happier life.